drugset / Trial / NCT03845010
Elimination of VPB With Ablation Versus Anti-arrhythmic Drug Treatment
RandomizedCrossoverOpen-labelTreatment
Summary
The ECTOPIA trial is a randomized, multicenter, clinical trial to assess elimination of ventricular premature beats (VPB) with catheter ablation versus optimal anti-arrhythmic drugs (AAD) treatment with flecainide/verapamil or sotalol.
Timeline
- Start
- 2019-02-12
- Primary completion
- 2023-01-17
- Completion
- 2023-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Verapamil | Other / unclassified | 240 mg | — |
| Comparator | flecainide | Small molecule | 200 mg | — |
| Comparator | sotalol | Small molecule | — | — |